RxDoctor Payments Data

Christina Julian, MD

Pain Medicine · Puyallup, WANPI 1013233428

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,468 of the $7,383 with a category attached, or 74.1%. 32 manufacturers reported payments, led by Nevro Corp. at 31.1% of the total. Reporting peaked in 2021 at $2,901 and has fallen 91.9% since, to $236 in 2025.

$7,383in general payments, 2019–2025

Across 181 payments — averaging $40.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$2K
  • Boston Scientific$2K
  • Abbott$562
  • AbbVie$496
  • Lilly USA, LLC$315
  • Medtronic$170
  • plus $1K from 26 others

What the payments were for

  • Travel & lodging$1,88626%
  • Food & beverage$5,46874%
  • Education$290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,383 in reported general payments places this provider in the 75th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$241,055
Medicare patients
230
Services billed
4,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl31$6,998
Oxycodone Hcl165$3,594
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen106$2,709
Buprenorphine11$2,672
Morphine Sulfate ErMorphine Sulfate78$2,263
Buprenorphine Hcl12$1,789
Gabapentin98$1,662
Pregabalin99$1,519
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen36$1,378
Hydromorphone Hcl39$587
Morphine Sulfate24$577
Tramadol Hcl46$538
Duloxetine Hcl24$438
Methocarbamol25$403
Baclofen28$295

Paid to pharmacies, not to this prescriber.

Other pain medicine in Puyallup

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →